Growing Our Potential for Patients
At Novartis Oncology, we have achieved a transformational milestone in our mission to help improve the lives of cancer patients. Learn how the acquisition of the GSK oncology portfolio enables us to deliver more therapies to more patients in their fight against cancer.
evolves our understanding of
how cancer develops on a genomic level, with potential
for better patient outcomes.
See compounds in all phases of development, from preclinical studies through large, randomized Phase III trials.
Novartis Oncology is advancing key areas of precision oncology such as signal transduction inhibition, antiangiogenesis and novel cytotoxins. Learn more
Key Therapeutic Targets
Novartis Oncology is exploring a spectrum of molecular pathways to identify therapeutic targets.
of collaboration brings
innovation to life.
As part of our commitment to patients and healthcare professionals, we have developed Alliance sites with patient support materials, educational materials, clinical trial information and more. Learn more
Novartis Oncology is currently conducting clinical trials in a number of disease areas. Learn more
Advocacy groups help us better understand patient needs and barriers to treatment success.
and related diseases
is about supporting patients
with more than medicine.
Learn about oncology-related resources that are of interest to patients. Learn more
"In February of 1999, I chose the music for my own funeral. Within weeks, I got out of my wheelchair to walk on my own."
Watch her story
Unique, dedicated global capabilities support our work. Learn more